Rethinking presbyopia: results of bilateral refractive lens exchange with trifocal intraocular lenses in 17 603 patients

医学 老花眼 眼科 镜头(地质) 人工晶状体 验光服务 人工晶状体 光学 物理
作者
Luis F. Brenner,Kristin Nistad,Urban Schonbeck
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:107 (7): 912-919 被引量:15
标识
DOI:10.1136/bjophthalmol-2021-319732
摘要

Purpose To evaluate the safety and effectiveness of bilateral refractive lens exchange (RLE) with trifocal intraocular lens (IOL) as the surgical treatment of presbyopia. Settings Memira AS. Norway, Sweden and Denmark. Design Multicentric retrospective interventional case series. Methods 17 603 consecutive patients submitted to bilateral presbyopic RLE with trifocal IOLs from 2013 to 2019. The main outcomes were manifest refraction spherical equivalent (MRSE), uncorrected distance (UDVA) and near (UNVA) visual acuity, corrected distance visual acuity (CDVA), vision gain/loss, safety and efficacy indices, IOL power calculation accuracy and rate of excimer laser enhancements. Results Three months postoperatively, the mean MRSE was 0.00±0.40 diopters (D), mean binocular UDVA was −0.03±0.09, with 14 470 patients (82.2%) with combined binocular UDVA and UNVA equal or better than 0.00 and Jaeger 3. Approximately 86% (n=30.124) of the eyes were within 0.50D of MRSE. Enhancement surgery was performed in 5810 eyes (16.5%). IOL power calculation refining improved accuracy and reduced enhancements rate from 20% in 2013 to 12% in 2019. Safety and efficacy indices were 0.98±0.11 and 0.85±0.18, respectively. Myopic eyes presented significant higher safety (1.00±0.19) and efficacy indices (0.87±0.19), with p<0.005. Approximately 0.38% (n=130) of the eyes lost two or more lines of CDVA, with cystoid macular oedema (n=53, 40.8%) and posterior capsular opacification (n=35, 26.9%) as the main causes. After proper care, the final incidence of two or more lines of vision loss was 0.08% (28 eyes). Conclusions Presbyopic RLE with trifocal IOL is a safe and effective modality of treatment for patients with presbyopia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
十八寒露的应助被LEETHEO采纳,获得10
刚刚
科研通AI6.3的应助被溧谦采纳,获得10
刚刚
许鑫蓁完成签到 ,获得积分10
1秒前
long-zhang完成签到,获得积分10
2秒前
俏皮诺言发布了新的文献求助10
2秒前
tjzbw发布了新的文献求助10
3秒前
烟花的应助被ZBN采纳,获得10
3秒前
sun完成签到,获得积分10
3秒前
xing_xing的应助被qrj采纳,获得20
5秒前
kk子的应助被SunAuole采纳,获得10
6秒前
7秒前
8秒前
坚定的可愁完成签到,获得积分10
10秒前
11秒前
liyuanyuan完成签到,获得积分10
11秒前
xhd183完成签到 ,获得积分10
12秒前
long-zhang发布了新的文献求助10
12秒前
赘婿的应助被xz采纳,获得10
13秒前
13秒前
彭于晏的应助被简单生活采纳,获得10
13秒前
Liy完成签到,获得积分10
13秒前
13秒前
14秒前
16秒前
可爱的函函的应助被xx采纳,获得10
16秒前
17秒前
18秒前
18秒前
深情安青的应助被Zhu采纳,获得10
19秒前
无私的青寒完成签到 ,获得积分10
19秒前
6366336发布了新的文献求助10
19秒前
21秒前
luxiaoyu发布了新的文献求助10
21秒前
kiwi发布了新的文献求助10
22秒前
倚栏听风完成签到 ,获得积分10
22秒前
23秒前
Ballas完成签到,获得积分10
23秒前
24秒前
24秒前
Seorina的应助被李一中采纳,获得10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485